Cytokinetics Earnings Surprises

  This CYTK earnings surprises page last updated 7/1/2026

CYTK Earnings Surprises

— Recent and historical earnings surprises for Cytokinetics (CYTK) from Q3 2012 to Q1 2026. The percentage surprise is calculated by comparing the actual reported earnings for the period, against the consensus analyst estimates ahead of the earnings report. The same calculation is also performed for revenue. This history of earnings surprises provide a great way to assess whether the company has a tendency to outperform or underperform expectations.
Cytokinetics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q1 2026 -1.65 -1.67 -0.02 (+1%)
Q4 2025 -1.41 -1.50 -0.09 (+6%)
Q3 2025 -1.58 -1.54 +0.04 (-3%)
Q2 2025 -1.35 -1.12 +0.23 (-17%)
Q4 2024 -1.17 -1.26 -0.09 (+8%)
Q3 2024 -1.26 -1.36 -0.10 (+8%)
Q2 2024 -1.06 -1.31 -0.25 (+24%)
Q1 2024 -1.14 -1.33 -0.19 (+17%)
Q4 2023 -0.97 -1.38 -0.41 (+42%)
Q3 2023 -0.74 -1.35 -0.61 (+82%)
Q2 2023 -1.23 -1.34 -0.11 (+9%)
Q1 2023 -1.20 -1.38 -0.18 (+15%)
Q4 2022 -1.21 -1.45 -0.24 (+20%)
Q3 2022 -1.17 -1.52 -0.35 (+30%)
Q2 2022 -1.02 -0.23 +0.79 (-77%)
Q1 2022 -0.94 -1.02 -0.08 (+9%)
Q4 2021 -0.84 -0.36 +0.48 (-57%)
Q3 2021 -0.76 -0.95 -0.19 (+25%)
Q2 2021 -0.65 -0.86 -0.21 (+32%)
Q1 2021 -0.58 -0.66 -0.08 (+14%)
Q2 2020 -0.57 -0.68 -0.11 (+19%)
Q1 2020 -0.50 -0.66 -0.16 (+32%)
Q4 2019 -0.44 -0.52 -0.08 (+18%)
Q2 2019 -0.50 -0.56 -0.06 (+12%)
Q1 2019 -0.47 -0.54 -0.07 (+15%)
Q4 2018 -0.52 -0.48 +0.04 (-8%)
Q3 2018 -0.51 -0.40 +0.11 (-22%)
Q1 2018 -0.51 -0.56 -0.05 (+10%)
Q3 2017 -0.61 -0.60 +0.01 (-2%)
Q2 2017 -0.59 -0.60 -0.01 (+2%)
Q1 2017 -0.27 -0.62 -0.35 (+130%)
Q4 2016 -0.40 0.16 +0.56 (-140%)
Q3 2016 -0.29 0.74 +1.03 (-355%)
Q2 2016 -0.31 -0.29 +0.02 (-6%)
Q1 2016 -0.34 -0.31 +0.03 (-9%)
Q4 2015 -0.32 -0.24 +0.08 (-25%)
Q3 2015 -0.30 -0.23 +0.07 (-23%)
Q2 2015 -0.24 -0.27 -0.03 (+13%)
Q1 2015 -0.12 -0.23 -0.11 (+92%)
Q4 2014 -0.17 0.23 +0.40 (-235%)
Q1 2014 -0.34 -0.27 +0.07 (-21%)
Q4 2013 -0.08 0.21 +0.29 (-362%)
Q3 2013 -0.10 -0.43 -0.33 (+330%)
Q2 2013 -0.54 -0.58 -0.04 (+7%)
Q3 2012 -0.66 -0.42 +0.24 (-36%)
Cytokinetics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q1 2026 8.49M 19.36M +10.87M (+128%)
Q4 2025 6.37M 17.75M +11.39M (+179%)
Q3 2025 5.85M 1.94M -3.92M (-67%)
Q2 2025 2.76M 66.77M +64.01M (+2319%)
Q4 2024 14.26M 16.93M +2.67M (+19%)
Q3 2024 1.20M 463000 -0.73M (+38583233%)
Q2 2024 920000 249000 -0.67M (-73%)
Q1 2024 900000 835000 -65000 (-7%)
Q4 2023 10.77M 1.67M -9.10M (-84%)
Q3 2023 20.24M 378000 -19.86M (+1867489%)
Q2 2023 2.50M 867000 -1.63M (+34679900%)
Q1 2023 2.09M 4.61M +2.52M (+121%)
Q4 2022 7.10M 1.96M -5.14M (-72%)
Q3 2022 2.96M 2.52M -0.45M (-15%)
Q2 2022 3.63M 88.97M +85.34M (+2351%)
Q1 2022 4.83M 1.15M -3.68M (-76%)
Q4 2021 6.20M 55.60M +49.40M (+797%)
Q3 2021 6.42M 5.44M -0.98M (-15%)
Q2 2021 5.45M 2.84M -2.61M (-48%)
Q1 2021 6.58M 6.55M -32000 (-0%)
Q2 2020 4.07M 3.59M -0.48M (-12%)
Q1 2020 5.01M 3.83M -1.19M (-24%)
Q4 2019 7.19M 5.21M -1.98M (-28%)
Q2 2019 6.99M 7.14M +147000 (+2%)
Q1 2019 6.86M 8.46M +1.60M (+23%)
Q4 2018 3.94M 9.38M +5.44M (+138%)
Q3 2018 3.15M 10.64M +7.49M (+238%)
Q1 2018 6.58M 5.27M -1.31M (-20%)
Q3 2017 7.12M 6.18M -0.94M (-13%)
Q2 2017 7.68M 3.05M -4.63M (-60%)
Q1 2017 20.81M 4.15M -16.66M (-80%)
Q4 2016 11.83M 33.14M +21.31M (+180%)
Q3 2016 8.44M 59.05M +50.61M (+600%)
Q2 2016 10.15M 5.80M -4.35M (-43%)
Q1 2016 7.38M 8.42M +1.04M (+14%)
Q4 2015 10.49M 9.76M -0.73M (-7%)
Q3 2015 11.24M 7.95M -3.29M (-29%)
Q2 2015 7.38M 6.54M -0.84M (-11%)
Q1 2015 10.08M 4.41M -5.67M (-56%)
Q4 2014 10.84M 21.76M +10.92M (+101%)
Q1 2014 7.69M 8.00M +310000 (+4%)
Q4 2013 19.14M 24.30M +5.16M (+27%)
Q3 2013 16.96M 12.60M -4.36M (-26%)
Q2 2013 3.20M 1.00M -2.20M (-69%)
Q3 2012 1.25M 1.70M +450000 (+36%)
Quotes delayed 20 minutes

Email EnvelopeFree CYTK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

eXoZymes Inc. - Common Stock (EXOZ): 7/1/2026 2:29 AM
MSC Industrial Direct Co (MSM): 7/1/2026 6:30 AM
General Mills (GIS): 7/1/2026 7:00 AM
FactSet Research Systems (FDS): 7/1/2026 7:00 AM
UniFirst (UNF): 7/1/2026 8:00 AM
Bassett Furniture Indus (BSET): 7/1/2026 After close
Greenbrier Companies (GBX): 7/1/2026 After close
Franklin Covey (FC): 7/1/2026 After close
Culp (CULP): 7/1/2026 After close
Lindsay (LNN): 7/2/2026 6:45 AM

More from the Next Earnings Dates Calendar

Earnings History:

Nike (NKE): 6/30/2026 After close
Constellation Brands (STZ): 6/30/2026 After close
Progress Software (PRGS): 6/30/2026 After close
AeroVironment (AVAV): 6/29/2026 After close
Concentrix (CNXC): 6/29/2026 After close
Netskope (NTSK): 6/29/2026 9:30 AM
Air T (AIRT): 6/29/2026 9:30 AM
Replimune Group (REPL): 6/29/2026 8:00 AM
Mexco Energy (MXC): 6/29/2026 6:20 AM
Exicure (XCUR): 6/26/2026 After close

More from the Earnings History archive
Cytokinetics (CYTK) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

DARE Historical Earnings
DAWN Historical Earnings
DBTX Historical Earnings
DCGO Historical Earnings
DCPH Historical Earnings
DCTH Historical Earnings
DERM Historical Earnings
DFFN Historical Earnings
DGX Historical Earnings
DHR Historical Earnings
On this page we presented the CYTK earnings surprises information for Cytokinetics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on CYTK (or any other given stock) can benefit from researching all of the Cytokinetics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Cytokinetics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about CYTK's next earnings report. In your continued research on Cytokinetics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for CYTK. Thanks for visiting, and the next time you need to research CYTK earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.
 

Cytokinetics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.